Fluoxetine: Fluox is the new funded brand

The funded brand of fluoxetine is changing from Arrow-Fluoxetine to Fluox.

On this page

What changed?

The funded brand of fluoxetine changed from Arrow-Fluoxetine to Fluox. Fluox has previously been funded, so this might mean some people are returning to a brand they've used before. 

Arrow-Fluoxetine and Fluox are both generic brands of fluoxetine. Fluoxetine is used to treat depression and related anxiety, as well as some other mental health conditions.

When Fluox became available 

  • From June 2020 Fluox dispersible tablets were available for patients.
  • From September 2020 Fluox capsules were available for patients.

If you want to keep using your current brand of fluoxetine, you can ask your pharmacist to check its price and availability. PHARMAC cannot guarantee the availability or price of Arrow-Fluoxetine.

Your new brand comes in capsules or dispersible tablets

Your previous brand: Arrow-Fluoxetine

Your new brand: Fluox

Green and yellow capsule

20 mg capsule

Dark purple and mint green capsule

20 mg capsule 

white round tablet with centre score

20 mg dispersible tablet

White oval tablet with a centre score

20 mg dispersible tablet

 (Not shown at actual size)

Fluox works the same as the other brands

  • Fluox will work in the same way as Arrow-Fluoxetine. Fluox has the same active ingredient and is delivered to the body in the same way.
  • Fluox has been thoroughly evaluated by Medsafe to ensure it’s safe.
  • You might have questions about changing your brand of medicine, but you shouldn’t notice any difference when you change to Fluox.
  • If you have any questions or concerns about changes to medicines, you should talk with your doctor, nurse or pharmacist.

There’s more information about medicines and changes to medicines on PHARMAC’s website.

Your brand is changing to help us fund other medicines

A decision to change a medicine, especially one as important as fluoxetine, isn’t taken lightly.

Our job is to make sure New Zealanders have access to the medicines they need. Making changes to medicines helps us achieve that by freeing up our limited budget to fund other medicines in the community.

For health care professionals

Healthcare professionals play an important role in supporting patients through changes to their medicines. We’d like to support you as you help your patients through the changes to fluoxetine.

Key points to tell your patients about Fluox:

  • Fluox has the same active ingredient (fluoxetine) as the other brands. This means the new brand of medication is just as safe and works the same as the old brand. Patients shouldn’t notice any difference in how it affects them.
  • Fluox comes in capsules and dispersible tablets and will look different from Arrow-Fluoxetine - this will not change how well the medicine works.
  • Fluox is a brand that has previously been funded.

Pharmacist update:

Arrow-Fluoxetine caps and tabs will be delisted on 1 February 2021.

Who to contact

If you have any questions or concerns about changing brands, talk with your doctor, nurse or pharmacist.

You can also get more information from us at enquiry@pharmac.govt.nz or 0800 66 00 50.